Down-regulation of TRPS1 stimulates epithelial-mesenchymal transition and metastasis through repression of FOXA1

Jin-Zhou Huang1, Min Chen1, Ming Zeng1

  • 1Institutes of Life and Health Engineering, Jinan University; and Biomedicine Research Centre, Third Affiliated Hospital of Guangzhou Medical University, People's Republic of China.

Insights

The tricho-rhino-phalangeal syndrome 1 gene (TRPS1) is crucial in cancer. Its down-regulation promotes metastasis by inhibiting FOXA1, while miR-373 drives this process, impacting patient survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The tricho-rhino-phalangeal syndrome 1 gene (TRPS1) is vital for bone, hair follicle, and kidney development.
  • The role of TRPS1 in cancer progression, particularly metastasis, remains largely unexplored.

Purpose of the Study:

  • To investigate the function of TRPS1 in cancer progression and metastasis.
  • To elucidate the molecular mechanisms by which TRPS1 influences epithelial-mesenchymal transition (EMT) and cancer cell invasion.

Main Methods:

  • Quantitative proteomics to identify TRPS1-interacting proteins.
  • In vitro and in vivo assays to assess cell migration, invasion, and metastasis.
  • Gene silencing and over-expression studies in cancer cell lines.
  • Analysis of TRPS1 and FOXA1 promoter binding using luciferase assays.

Main Results:

  • TRPS1 down-regulation correlates with distant metastasis, tumor recurrence, and poor survival in cancer patients.
  • TRPS1 silencing promotes EMT, migration, invasion, and metastasis, while TRPS1 over-expression inhibits these processes.
  • TRPS1 directly activates FOXA1 transcription, a negative regulator of EMT. TRPS1 knockdown leads to FOXA1 down-regulation.
  • miR-373 induces TRPS1 down-regulation, thereby promoting EMT and metastasis by repressing FOXA1.

Conclusions:

  • TRPS1 functions as a tumor suppressor by activating FOXA1 transcription and inhibiting EMT and metastasis.
  • miR-373-mediated down-regulation of TRPS1 is a key mechanism driving cancer progression and metastasis.
  • TRPS1's role as a transcriptional activator in cancer contrasts with its previously known function as a repressor.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.0K